Small Molecules
21 June 2019
Turning Point Therapeutics Initiates Phase 2 Registrational Portion of TRIDENT-1 Clinical Study18 June 2019
Lynparza approved in the EU for 1st-line maintenance treatment of BRCA-mutated advanced ovarian cancer15 June 2019
Kura Oncology Announces Positive Phase 2 Trial of Tipifarnib in Peripheral T-Cell Lymphoma15 June 2019
ORYZON Presents Preliminary Dose Finding Results of Phase II Trial With Iadademstat in AMLNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports